KOL Bio-Medical Closes First babyLance™ Heel Incision Device Sale with Slidell Memorial Hospital

‘Ease of Use’ a Factor in NICU Manager’s Decision
Spread the Word
Listed Under

Heel Stick
Medical Device


Norcross - Georgia - US

Nov. 30, 2010 - PRLog -- SLIDELL, La. And NORCROSS, Ga. – Barely a month after announcing medical product distributor KOL Bio-Medical Instruments as a distributor for its new babyLance™ infant heel incision device, MediPurpose® today announced KOL’s first sale of babyLance™ to Slidell Memorial Hospital.

Last month, a KOL sales representative was visiting Slidell’s neonatal intensive care unit (NICU) to provide in-service for an unrelated medical product. But after a chance opportunity to demonstrate the babyLance™ to the NICU manager, an on-the-spot agreement was reached for an order of the babyLance™ Preemie (BLP) infant heel incision device.

Although delighted to learn of the NICU manager’s swift satisfaction with babyLance™, MediPurpose® President and COO Randy Prather was not surprised with how quickly neonatal caregivers embrace the infant heel incision device.

“After nearly 18 months of intense medical device research and development for this unique neonatal heel stick, when we launched babyLance™ last August, we were quite confident that our heel incision device was going to be very well accepted,” said Prather.

Valued for its ease of use, the babyLance™ can also be recognized as one of the safest heel incision devices in the world, said Prather. Earlier this month, MediPurpose received  510(k) clearance from the U.S. Food and Drug Administration to market the babyLance™ infant heel incision device with sharps prevention indications—the first and only neonatal heel stick to receive this clearance.

On August 26, the FDA and the Centers for Disease Control and Prevention issued health notifications stating that lancing devices should never be used on more than one patient because of the risk of transmitting bloodborne pathogens.

babyLance™ is a single-use heel incision device utilized to obtain a blood sample from the heel of newborn (babyLance™ BLN) and preemie (babyLance™ BLP) infants. It has four integrated components that were crucial for its 510(k) with sharps prevention indications clearance:

   * A locking mechanism to prevent accidental activation of the device.

   * A housing that conceals the blade before and after the device is used.

   * An internal spring that automatically retracts the blade after use.

   * A stop feature that disables the device after a single use.

More information about babyLance™—including demonstration videos and no-cost product sample requests—is available at http://www.medipurpose.com/babylance/.

About KOL Bio-Medical Instruments
Founded in 1971 in Fairfax, Virginia, KOL Bio-Medical is a Service Disabled Veteran Owned specialty distributor committed to bringing emerging medical technologies to the market.

For three decades, KOL’s highly trained and experienced sales force has helped pioneer and introduce advanced medical devices to hospitals and clinicians throughout the Eastern United States.

KOL’s business model is to seek out and partner with the most ethical and innovative client manufacturers who have a strong desire to enhance the healthcare value chain by improving patient health and/or dramatically reducing costs in the system. By establishing partnerships with those companies, KOL has succeeded as a singular, innovative entity comfortable in marketing the latest technological advances.

For more information, please visit http://www.kolbio.com.

About Slidell Memorial Hospital
As a 182-bed acute care community hospital located in the heart of Slidell, Louisiana, Slidell Memorial Hospital provides access to the latest treatments and technology and expert physicians.

For more information about Slidell Memorial Hospital, please visit http://www.slidellmemorial.org.

# # #

About MediPurpose
Founded in 1999, MediPurpose is a leading medical device company headquartered in Singapore, with offices in the United States and Europe.

Known for its popular SurgiLance® safety lancet and babyLance™ heel incision device, MediPurpose has leveraged its success in the medical device industry to become a master medical product distributor that provides unique solutions for both medical product manufacturers and medical product distributors.

MediPurpose's Innovation division offers angel funding and developmental expertise for new medical device inventors and innovative medical product companies that seek entrance into new medical device markets.

For more information about MediPurpose’s medical products and solutions for inventors, innovators, manufacturers and distributors, please visit http://www.medipurpose.com.
Source:Derek Rudnak | MediPurpose®
Email:***@medipurpose.com Email Verified
Tags:Medipurpose, Babylance, Kol, Slidell, Hospital, Heelstick, Heel Stick, Medical Device, Infant, Neonatal, Louisianai
Industry:Business, Health, Science
Location:Norcross - Georgia - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Page Updated Last on: Aug 15, 2011
babyLance™ Safety Heelsticks PRs
Trending News
Top Daily News
Top Weekly News

Like PRLog?
Click to Share